IE62440B1 - Novel chimeric antibodies - Google Patents

Novel chimeric antibodies

Info

Publication number
IE62440B1
IE62440B1 IE1989A IE1989A IE62440B1 IE 62440 B1 IE62440 B1 IE 62440B1 IE 1989 A IE1989 A IE 1989A IE 1989 A IE1989 A IE 1989A IE 62440 B1 IE62440 B1 IE 62440B1
Authority
IE
Ireland
Prior art keywords
ser
derivatives
chimeric monoclonal
formula
chimeric
Prior art date
Application number
IE1989A
Other languages
English (en)
Other versions
IE890019L (en
Inventor
Norman Hardman
Laura Lee Gill
De Ronald F J Winter
Katherin Wagner
Christoph Heusser
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888800077A external-priority patent/GB8800077D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE890019L publication Critical patent/IE890019L/en
Publication of IE62440B1 publication Critical patent/IE62440B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IE1989A 1988-01-05 1989-01-04 Novel chimeric antibodies IE62440B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888800077A GB8800077D0 (en) 1988-01-05 1988-01-05 Novel chimeric antibodies
GB888820099A GB8820099D0 (en) 1988-01-05 1988-08-24 Novel chimeric antibodies

Publications (2)

Publication Number Publication Date
IE890019L IE890019L (en) 1989-07-05
IE62440B1 true IE62440B1 (en) 1995-02-08

Family

ID=26293262

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1989A IE62440B1 (en) 1988-01-05 1989-01-04 Novel chimeric antibodies

Country Status (10)

Country Link
EP (1) EP0323806B1 (enExample)
JP (1) JPH02154696A (enExample)
AU (1) AU625613B2 (enExample)
DE (1) DE3879452T2 (enExample)
DK (1) DK172444B1 (enExample)
ES (1) ES2053810T3 (enExample)
GR (1) GR3007853T3 (enExample)
HK (1) HK156695A (enExample)
IE (1) IE62440B1 (enExample)
PT (1) PT89384B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0617127A1 (en) * 1987-12-31 1994-09-28 Tanox Biosystems, Inc. Antigenic epitopes on B cell-bound IgE Immunoglobulins
IL89491A0 (en) * 1988-11-17 1989-09-10 Hybritech Inc Bifunctional chimeric antibodies
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DE3900534A1 (de) * 1989-01-10 1990-07-12 Boehringer Mannheim Gmbh Diagnostischer nachweis unter verwendung von chimaeren antikoerpern
US5081235A (en) * 1989-07-26 1992-01-14 City Of Hope Chimeric anti-cea antibody
US5580774A (en) * 1989-07-31 1996-12-03 Eli Lilly And Company Chimeric antibodies directed against a human glycoprotein antigen
US20030225254A1 (en) 1989-08-07 2003-12-04 Rathjen Deborah Ann Tumour necrosis factor binding ligands
EP0486526B2 (en) 1989-08-07 2001-03-07 Peptech Limited Tumour necrosis factor binding ligands
CA2022959C (en) * 1989-08-10 2001-03-20 Hiroaki Maeda Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin
EP0457875A4 (en) * 1989-11-13 1993-03-03 Xoma Corporation Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
DE69127749T2 (de) * 1990-03-20 1998-04-16 The Trustees Of Columbia University In The City Of New York, New York, N.Y. Chimäre antikörper mit rezeptor-bindenden liganden anstelle ihrer konstanten region
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
GB2276169A (en) * 1990-07-05 1994-09-21 Celltech Ltd Antibodies specific for carcinoembryonic antigen
GB9020282D0 (en) 1990-09-17 1990-10-31 Gorman Scott D Altered antibodies and their preparation
US5612034A (en) * 1990-10-03 1997-03-18 Redcell, Inc. Super-globuling for in vivo extended lifetimes
GB9109645D0 (en) * 1991-05-03 1991-06-26 Celltech Ltd Recombinant antibodies
US6797492B2 (en) 1991-05-17 2004-09-28 Merck & Co., Inc. Method for reducing the immunogenicity of antibody variable domains
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
GB9317423D0 (en) * 1993-08-21 1993-10-06 Imp Cancer Res Tech Monoclonal antibodies
AU707440B2 (en) 1994-03-29 1999-07-08 Celltech Therapeutics Limited Antibodies against E-selectin
CU22615A1 (es) 1994-06-30 2000-02-10 Centro Inmunologia Molecular Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
US5874540A (en) 1994-10-05 1999-02-23 Immunomedics, Inc. CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
AU4373197A (en) * 1996-09-19 1998-04-14 Diagnocure Inc. Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof
DE19911329A1 (de) * 1998-03-27 2000-09-21 Benes Ivan Friedrich Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung
EP1598671A1 (en) * 1999-10-28 2005-11-23 Agensys, Inc. Diagnosis and therapy of cancer using SGP28-related molecules
KR20050065587A (ko) 2002-10-08 2005-06-29 이뮤노메딕스, 인코오포레이티드 항체 치료법
EP2210903A1 (en) * 2009-01-21 2010-07-28 Monoclonal Antibodies Therapeutics Anti-CD160 monoclonal antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations

Also Published As

Publication number Publication date
PT89384B (pt) 1993-09-30
PT89384A (pt) 1990-02-08
AU625613B2 (en) 1992-07-16
EP0323806B1 (en) 1993-03-17
EP0323806A1 (en) 1989-07-12
DK2189A (da) 1989-07-06
ES2053810T3 (es) 1994-08-01
DE3879452D1 (de) 1993-04-22
IE890019L (en) 1989-07-05
HK156695A (en) 1995-10-13
JPH02154696A (ja) 1990-06-14
DK2189D0 (da) 1989-01-04
DK172444B1 (da) 1998-07-27
GR3007853T3 (enExample) 1993-08-31
AU2759588A (en) 1989-07-06
DE3879452T2 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
US5843708A (en) Chimeric antibodies
US6020153A (en) Chimeric antibodies
EP0323806B1 (en) Novel chimeric antibodies
Queen et al. A humanized antibody that binds to the interleukin 2 receptor.
CA1340456C (en) Chimeric rodent/human immunoglobulins specific for tumor-associated antigens
EP1728864B1 (en) Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
AU634314B2 (en) Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
JP3415171B2 (ja) 成長因子リセプターに特異的な組換抗体
JP2935520B2 (ja) ガン治療に用いられる新規高親和性改変抗体系統群
AU673347B2 (en) Genetically engineered antibodies
US5993813A (en) Family of high affinity, modified antibodies for cancer treatment
TW202438528A (zh) 特異性結合Ｃｌａｕｄｉｎ １８．２的抗體及其製法和應用
US6051225A (en) Family of high affinity, modified antibodies for cancer treatment
CA2106719C (en) Reshaped monoclonal antibodies against an immunoglobulin isotype
IE920434A1 (en) IgE-Receptor-Antibodies
CA2060626A1 (en) Chimeric antiidiotypic monoclonal antibodies
CA2071305A1 (en) Anti-hiv antibodies
JPS63112995A (ja) 腫瘍関連抗原に特異的なキメラ齧歯類／ヒト免疫グロブリン
CA2057951A1 (en) Chimeric antibodies and their use

Legal Events

Date Code Title Description
MM4A Patent lapsed